Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5.
Saved in:
| Title: | Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5. |
|---|---|
| Authors: | Sachs J; Bio-Pharmaceutical Chemistry and Molecular Pharmacology, Faculty of Applied Natural Sciences, Technische Hochschule Köln, Leverkusen, Germany., Döhl K; Institute of Biochemistry, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany., Weber A; Institute of Bioorganic Chemistry, Heinrich-Heine-Universität Düsseldorf im Forschungszentrum Jülich, Jülich, Germany., Bonus M; Institute for Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany., Ehlers F; Bio-Pharmaceutical Chemistry and Molecular Pharmacology, Faculty of Applied Natural Sciences, Technische Hochschule Köln, Leverkusen, Germany., Fleischer E; MicroCombiChem GmbH, Wiesbaden, Germany., Klinger A; MicroCombiChem GmbH, Wiesbaden, Germany., Gohlke H; Institute for Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.; John von Neumann Institute for Computing, Jülich Supercomputing Centre and Institute for Complex Systems - Structural Biochemistry, Forschungszentrum Jülich GmbH, Jülich, Germany., Pietruszka J; Institute of Bioorganic Chemistry, Heinrich-Heine-Universität Düsseldorf im Forschungszentrum Jülich, Jülich, Germany.; IBG-1: Biotechnology, Forschungszentrum Jülich, Jülich, Germany., Schmitt L; Institute of Biochemistry, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany., Teusch N; Bio-Pharmaceutical Chemistry and Molecular Pharmacology, Faculty of Applied Natural Sciences, Technische Hochschule Köln, Leverkusen, Germany. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2019 Apr 16; Vol. 10, pp. 400. Date of Electronic Publication: 2019 Apr 16 (Print Publication: 2019). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31040786 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sachs+J%22">Sachs J</searchLink>; Bio-Pharmaceutical Chemistry and Molecular Pharmacology, Faculty of Applied Natural Sciences, Technische Hochschule Köln, Leverkusen, Germany.<br /><searchLink fieldCode="AU" term="%22Döhl+K%22">Döhl K</searchLink>; Institute of Biochemistry, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Weber+A%22">Weber A</searchLink>; Institute of Bioorganic Chemistry, Heinrich-Heine-Universität Düsseldorf im Forschungszentrum Jülich, Jülich, Germany.<br /><searchLink fieldCode="AU" term="%22Bonus+M%22">Bonus M</searchLink>; Institute for Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Ehlers+F%22">Ehlers F</searchLink>; Bio-Pharmaceutical Chemistry and Molecular Pharmacology, Faculty of Applied Natural Sciences, Technische Hochschule Köln, Leverkusen, Germany.<br /><searchLink fieldCode="AU" term="%22Fleischer+E%22">Fleischer E</searchLink>; MicroCombiChem GmbH, Wiesbaden, Germany.<br /><searchLink fieldCode="AU" term="%22Klinger+A%22">Klinger A</searchLink>; MicroCombiChem GmbH, Wiesbaden, Germany.<br /><searchLink fieldCode="AU" term="%22Gohlke+H%22">Gohlke H</searchLink>; Institute for Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.; John von Neumann Institute for Computing, Jülich Supercomputing Centre and Institute for Complex Systems - Structural Biochemistry, Forschungszentrum Jülich GmbH, Jülich, Germany.<br /><searchLink fieldCode="AU" term="%22Pietruszka+J%22">Pietruszka J</searchLink>; Institute of Bioorganic Chemistry, Heinrich-Heine-Universität Düsseldorf im Forschungszentrum Jülich, Jülich, Germany.; IBG-1: Biotechnology, Forschungszentrum Jülich, Jülich, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitt+L%22">Schmitt L</searchLink>; Institute of Biochemistry, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Teusch+N%22">Teusch N</searchLink>; Bio-Pharmaceutical Chemistry and Molecular Pharmacology, Faculty of Applied Natural Sciences, Technische Hochschule Köln, Leverkusen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2019 Apr 16; Vol. 10, pp. 400. <i>Date of Electronic Publication: </i>2019 Apr 16 (<i>Print Publication: </i>2019). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31040786 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2019.00400 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 400 Titles: – TitleFull: Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sachs J – PersonEntity: Name: NameFull: Döhl K – PersonEntity: Name: NameFull: Weber A – PersonEntity: Name: NameFull: Bonus M – PersonEntity: Name: NameFull: Ehlers F – PersonEntity: Name: NameFull: Fleischer E – PersonEntity: Name: NameFull: Klinger A – PersonEntity: Name: NameFull: Gohlke H – PersonEntity: Name: NameFull: Pietruszka J – PersonEntity: Name: NameFull: Schmitt L – PersonEntity: Name: NameFull: Teusch N IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 04 Text: 2019 Apr 16 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 10 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |